Transgenic mouse models of lipoprotein metabolism and atherosclerosis.
- 15 September 1993
- journal article
- review article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 90 (18) , 8314-8318
- https://doi.org/10.1073/pnas.90.18.8314
Abstract
Lipoprotein transport genes have either been added to the germ line of mice by transgenic techniques or knocked out by homologous recombination in embryonic stem cells. The resultant over- or underexpression of these genes has resulted in new insights about how these genes function in the body and their role in lipoprotein metabolism. Either singly or in combination, these genetic modifications can be used to engineer the mouse to make it a better model for human lipoprotein disorders and atherosclerosis.Keywords
This publication has 35 references indexed in Scilit:
- Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemiaJournal of Biological Chemistry, 1993
- A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice.Journal of Biological Chemistry, 1993
- Intestinal expression of the human apoA-I gene in transgenic mice is controlled by a DNA region 3' to the gene in the promoter of the adjacent convergently transcribed apoC-III gene.1993
- Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanistic studies in human Apo A-I transgenic and control mice.Journal of Clinical Investigation, 1993
- Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a).Journal of Biological Chemistry, 1992
- Atherogenesis in transgenic mice expressing human apolipoprotein(a)Nature, 1992
- Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.Journal of Clinical Investigation, 1992
- Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B.Journal of Clinical Investigation, 1992
- LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantationCell, 1992
- High level expression of human apolipoprotein A-I in transgenic rats raises total serum high density lipoprotein cholesterol and lowers rat apolipoprotein A-ITransgenic Research, 1992